NEW YORK (GenomeWeb News) – Pressure BioSciences saw revenues in its third quarter climb 7 percent year over year as revenues derived from its Pressure Cycling Technology grew 10 percent, the company said today.

The South Easton, Mass.-based firm said that total revenues reached $420,762 for the three months ended Sept. 30, compared to $391,616 a year ago. Revenues from PCT products, services, and other were $327,958, compared to $297,867 a year ago, while grant revenues narrowed to $92,804 from $93,749.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.